EscharEx (EX-03) + Placebo (Gel vehicle)
Phase 3Recruiting 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Venous Leg Ulcer (VLU)
Conditions
Venous Leg Ulcer (VLU)
Trial Timeline
Jun 1, 2025 → Mar 1, 2027
NCT ID
NCT06568627About EscharEx (EX-03) + Placebo (Gel vehicle)
EscharEx (EX-03) + Placebo (Gel vehicle) is a phase 3 stage product being developed by MediWound for Venous Leg Ulcer (VLU). The current trial status is recruiting. This product is registered under clinical trial identifier NCT06568627. Target conditions include Venous Leg Ulcer (VLU).
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06568627 | Phase 3 | Recruiting |
| NCT06690177 | Phase 2 | Recruiting |
Competing Products
20 competing products in Venous Leg Ulcer (VLU)